ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

In Brief: Hatch To Speak At AACI Dinner; NIH Plans 1987 Centennial; Cox To Head Columbia Radiotherapy

May 24, 1985

FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere

October 8, 1982

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

Working Group Considering formal Cap On size of Cancer Center Support Grants

March 22, 1996

Judge Rules Privacy Act Not Applicable In Bernard Fisher’s Suit Against HHA

July 5, 1996